PHK
INBX

Point72 Hong Kong’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Point72 Hong Kong’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,879
Closed -$33K – 2598
2022
Q2 		$33K Buy
2,879
+1,748
+155% +$25.7K ﹤0.01% 1455
2022
Q1 		$25K Buy
1,131
+576
+104% +$14.7K ﹤0.01% 1495
2021
Q4 		$24K Buy
+555
New +$22.2K ﹤0.01% 1518

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Point72 Hong Kong's INBX Position: Q3 2022 in Review

Point72 Hong Kong sold out of Inhibrx, Inc. Common Stock (INBX) in Q3 2022, closing a stake of 2,879 shares — an estimated $33K sold.

Point72 Hong Kong first reported a position in INBX in Q4 2021 and held it in 3 quarters. The position peaked at $33K in Q2 2022. 102 funds tracked by Wall St. Rank hold INBX as of Q3 2022.

  • Point72 Hong Kong reported no remaining Inhibrx, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 2,879 Inhibrx, Inc. Common Stock shares in Q3 2022, an estimated $33K.
  • Point72 Hong Kong first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Point72 Hong Kong's Inhibrx, Inc. Common Stock position peaked at $33K in Q2 2022.
  • 102 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.